Related Experiment Video

Updated: May 16, 2026

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge
09:53

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge

Published on: June 15, 2018

[Effects of microRNA-1 on negatively regulating L-type calcium channel beta2 subunit gene expression during cardiac

Yang Wu1, Peng Geng, Yu-Qin Wang

  • 1Institute of Navigation Medicine, Nantong University, Nantong 226001, China. wy@ntu.edu.cn

Zhongguo Ying Yong Sheng Li Xue Za Zhi = Zhongguo Yingyong Shenglixue Zazhi = Chinese Journal of Applied Physiology
|November 20, 2012
PubMed
Abstract

Insights

MicroRNA-1 (miR-1) negatively regulates the L-type calcium channel beta2 subunit (Cavbeta 2) in cardiomyocyte hypertrophy. Upregulating miR-1 or downregulating Cavbeta 2 attenuates hypertrophy.

Area of Science:

  • Molecular biology
  • Cardiovascular research
  • Gene regulation

Context:

  • Cardiomyocyte hypertrophy is a significant risk factor for heart failure.
  • MicroRNAs play crucial roles in regulating cardiac function.
  • The L-type calcium channel beta2 subunit (Cavbeta 2) is implicated in cardiac pathophysiology.

Purpose:

  • To investigate the inhibitory role of microRNA-1 (miR-1) on Cavbeta 2 expression in cardiomyocyte hypertrophy.
  • To elucidate the underlying molecular mechanisms.

Summary:

  • Cardiomyocyte hypertrophy was induced using isoproterenol (ISO).
  • miR-1 expression was reduced, while Cavbeta 2 expression was increased during hypertrophy.
  • miR-1 directly targets Cavbeta 2, suppressing its expression and consequently reducing cardiomyocyte size and hypertrophy markers (ANP, beta-MHC).
  • Conversely, downregulating Cavbeta 2 inhibited hypertrophy.

Impact:

  • This study identifies Cavbeta 2 as a direct target of miR-1 in the context of cardiac hypertrophy.
  • The findings reveal a novel regulatory pathway involving miR-1 and Cavbeta 2 in cardiac remodeling.
  • Targeting the miR-1/Cavbeta 2 axis may offer therapeutic strategies for preventing or treating cardiomyocyte hypertrophy.

More Related Videos

Tissue-specific miRNA Expression Profiling in Mouse Heart Sections Using In Situ Hybridization08:22

Tissue-specific miRNA Expression Profiling in Mouse Heart Sections Using In Situ Hybridization

Published on: September 15, 2018

Related Concept Videos

Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...